substance p has been researched along with enalapril in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 9 (69.23) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Benjamin, N; Webb, DJ | 1 |
| Ferner, RE; Kamali, F; Rawlins, MD | 1 |
| Lantz, I; Nyberg, F; Terenius, L | 1 |
| Katsumata, U; Sasaki, H; Sekizawa, K; Takishima, T; Ujiie, Y | 1 |
| Bunnett, NW; Orloff, MS; Turner, AJ | 1 |
| Andersson, KE; Andersson, SI; Ekman, R; Thysell, H | 1 |
| Ebihara, A; Fujimura, A; Shiga, T; Sunaga, K | 1 |
| Chadwick, IG; Jackson, PR; Kraskiewicz, M; Ramsay, LE; Yeo, WW | 1 |
| Chan, CC; Rodger, IW; Savoie, C; Tousignant, C | 1 |
| Hirayama, Y; Ichinose, M; Kageyama, N; Miura, M; Shirato, K; Tomaki, M; Yamauchi, H | 1 |
| Bunnett, NW; Emanueli, C; Figini, M; Geppetti, P; Grady, EF; Madeddu, P; Parisi, D; Regoli, D | 1 |
| Harford-Wright, E; Thornton, E; Vink, R | 1 |
| Choi, JG; Choi, SR; Hwang, J; Kang, DW; Kim, HW; Lee, M; Shin, HJ | 1 |
4 trial(s) available for substance p and enalapril
| Article | Year |
|---|---|
The effects of enalapril and sulindac on the dermal response to substance P and neurokinin A.
Topics: Adult; Double-Blind Method; Enalapril; Humans; Male; Neurokinin A; Random Allocation; Skin; Skin Tests; Substance P; Sulindac | 1991 |
Bradykinin-induced cough reflex markedly increases in patients with cough associated with captopril and enalapril.
Topics: Adult; Aerosols; Aged; Bradykinin; Captopril; Citrates; Citric Acid; Cough; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Reflex; Respiratory Function Tests; Substance P | 1991 |
Chronopharmacology of enalapril in hypertensive patients.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Cough; Dinoprostone; Enalapril; Enalaprilat; Female; Half-Life; Humans; Hypertension; Male; Middle Aged; Substance P | 1995 |
Resolution of ACE inhibitor cough: changes in subjective cough and responses to inhaled capsaicin, intradermal bradykinin and substance-P.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Capsaicin; Cough; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Substance P | 1995 |
9 other study(ies) available for substance p and enalapril
| Article | Year |
|---|---|
The effect of local converting enzyme inhibition on the dilator response to substance P in the human forearm.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Dose-Response Relationship, Drug; Enalapril; Forearm; Humans; Male; Regional Blood Flow; Substance P; Vasodilation | 1990 |
Molecular heterogeneity of angiotensin converting enzyme in human cerebrospinal fluid.
Topics: Amino Acid Sequence; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chlorides; Chromatography, High Pressure Liquid; Enalapril; Enkephalin, Leucine; Humans; Molecular Sequence Data; Molecular Weight; Neurokinin A; Peptidyl-Dipeptidase A; Radioimmunoassay; Substance P | 1991 |
Catabolism of substance P and neurotensin in the rat stomach wall is susceptible to inhibitors of angiotensin converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Chromatography, High Pressure Liquid; Enalapril; Enalaprilat; Gastric Mucosa; Glycopeptides; Kinetics; Male; Neurotensin; Peptide Fragments; Rats; Rats, Inbred Strains; Substance P; Thermolysin | 1986 |
Angiotensin-converting enzyme inhibition, cough and the serum concentration of substance P.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cough; Enalapril; Humans; Hypertension; Substance P | 1988 |
Involvement of NK1 and NK2 receptors in pulmonary responses elicited by non-adrenergic, non-cholinergic vagal stimulation in guinea-pigs.
Topics: Animals; Benzamides; Bronchi; Bronchoconstriction; Capillary Permeability; Enalapril; Guinea Pigs; Male; Piperidines; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Substance P; Thiorphan; Trachea; Vagus Nerve | 1995 |
Angiotensin converting enzyme (ACE) inhibitor-induced cough and substance P.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cough; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Sputum; Substance P; Time Factors | 1996 |
Acute ACE inhibition causes plasma extravasation in mice that is mediated by bradykinin and substance P.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Coloring Agents; Data Interpretation, Statistical; Enalapril; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Indicators and Reagents; Indoles; Injections, Intravenous; Male; Mice; Mice, Inbred C57BL; Neurokinin-1 Receptor Antagonists; Organometallic Compounds; Piperidines; Quinuclidines; Substance P; Time Factors | 1998 |
Angiotensin-converting enzyme (ACE) inhibitors exacerbate histological damage and motor deficits after experimental traumatic brain injury.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Brain Injuries; Captopril; Cerebral Cortex; Disease Models, Animal; Enalapril; Gene Expression Regulation; Male; Motor Activity; Movement Disorders; Rats; Rats, Sprague-Dawley; Rotarod Performance Test; Substance P | 2010 |
Inhibition of angiotensin converting enzyme increases PKCĪ²I isoform expression via activation of substance P and bradykinin receptors in cultured astrocytes of mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Astrocytes; Captopril; Enalapril; Mice; Peptidyl-Dipeptidase A; Protein Kinase C-alpha; Receptors, Bradykinin; Substance P | 2023 |